These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37891608)

  • 1. PACAP-Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer's disease.
    Wang Q; Wang Y; Li S; Shi J
    Alzheimers Res Ther; 2023 Oct; 15(1):184. PubMed ID: 37891608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity.
    Han P; Tang Z; Yin J; Maalouf M; Beach TG; Reiman EM; Shi J
    Neurobiol Aging; 2014 Sep; 35(9):2064-71. PubMed ID: 24726470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice.
    Rat D; Schmitt U; Tippmann F; Dewachter I; Theunis C; Wieczerzak E; Postina R; van Leuven F; Fahrenholz F; Kojro E
    FASEB J; 2011 Sep; 25(9):3208-18. PubMed ID: 21593432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
    Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
    JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary Adenylate Cyclase-Activating Polypeptide Protects Against Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion.
    Guo X; Tian Y; Yang Y; Li S; Guo L; Shi J
    Mol Neurobiol; 2021 Sep; 58(9):4309-4322. PubMed ID: 33999349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y; Zhang Y; Chen Q; Liu Y; Wei X; Wu M; Zhang K; Liu Y; Wei W
    J Alzheimers Dis; 2023; 91(3):1197-1214. PubMed ID: 36565127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy.
    Guo X; Lv J; Lu J; Fan L; Huang X; Hu L; Wang J; Shen X
    Neuropharmacology; 2018 Mar; 130():77-91. PubMed ID: 29197516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease.
    Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L
    J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Shu M; Zhang W; Jin X; Zeng L; Xiang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 49(6):750-757. PubMed ID: 33448178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway.
    Ebrahim N; Al Saihati HA; Alali Z; Aleniz FQ; Mahmoud SYM; Badr OA; Dessouky AA; Mostafa O; Hussien NI; Farid AS; El-Sherbiny M; Salim RF; Forsyth NR; Ali FEM; Alsabeelah NF
    Biomed Pharmacother; 2024 Jul; 176():116836. PubMed ID: 38850660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
    Wang C; Zhang X; Teng Z; Zhang T; Li Y
    Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway.
    Wang X; Jia J
    Biomed Pharmacother; 2023 May; 161():114473. PubMed ID: 36889111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease.
    Lamine-Ajili A; Fahmy AM; Létourneau M; Chatenet D; Labonté P; Vaudry D; Fournier A
    Biochim Biophys Acta; 2016 Apr; 1862(4):688-695. PubMed ID: 26769362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
    Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
    J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide: Protective effects in stroke and dementia.
    Nonaka N; Banks WA; Shioda S
    Peptides; 2020 Aug; 130():170332. PubMed ID: 32445876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
    He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
    Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of nicotinamide mononucleotide on Alzheimer's disease through activating autophagy and anti-oxidative stress.
    Ma RY; Li L; Yang H; Zou B; Ma RX; Zhang Y; Wu MM; Chen P; Yao Y; Li J
    Biomed Pharmacother; 2024 Sep; 178():117199. PubMed ID: 39053426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.